Simplify Logo

Full-Time

Scientist I

Formulation

Posted on 8/26/2024

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function improvement

Biotechnology
Healthcare

Compensation Overview

$128k - $156kAnnually

Mid

San Bruno, CA, USA

Requires onsite presence in South San Francisco, California for a minimum of three days per week. May involve travel to oversee development and manufacturing activities at CROs/CMOs.

Category
Lab & Research
Life Sciences
Required Skills
Communications
Data Analysis
PowerPoint/Keynote/Slides
Requirements
  • Ph.D. in Pharmaceutical Science, Chemistry, Chemical Engineering, or related discipline with 2+ years of experience
  • Strong background in oral solid dosage forms including immediate and controlled released formulations
  • Hands-on experience with various unit operation processes in lab scales for oral solid dosages
  • Proficient in designing and executing experiments, analyzing samples in the formulation laboratory, and drawing conclusions and recommendation based on experimental data
  • Sound understanding of the principles and practices of pharmaceutical science, with the ability to integrate and apply this knowledge effectively to formulation and process development
  • Capable of applying Design of Experiment (DoE) statistical approaches during process optimization and scale-up, including knowledge of statistical programs for data analysis
  • Comfortable performing analytical tests and solid-state characterization independently, including techniques such as Dissolution, HPLC, DSC, TGA, XRPD, SEM, Laser Diffraction Particle Size Analyzer and Light Microscopy
  • Experienced in pre-clinical formulation preparation and conducting pre-formulation studies
  • Demonstrated ability to effectively work on multiple projects and capability of prioritizing various tasks under tight timelines
  • Comfortable in dynamic, fast-paced, and high demanding environments
  • Excellent interpersonal, communication and decision-making skills
  • Proficient in writing technical reports (using Word), summarizing processing data (Excel), and facilitating discussions and conclusions (PowerPoint presentations)
  • Team player who enjoys working in the multidisciplinary environment
Responsibilities
  • Conduct prototype formulation and process development utilizing internal formulation laboratory capabilities, and support tech transfer and scale-up to CMO/CRO for continuous development
  • Summarize experimental findings, review, and interpret study, results, assemble data packages
  • Participate in activities at CRO/CMO for pre-formulation study, formulation and process development, as well as CTM manufacturing and packaging for drug products
  • Review and prepare protocols and batch records, analyze in-process and analytical data, draw scientific conclusions, as well as prepare study reports and presentations
  • Provide support to DMPK and Pharmacology team regarding pre-clinical formulation optimization and preparation
  • Collaborate with process chemistry team for crystal form/salt selection and polymorph screening activities
  • Characterize formulations prepared by CMO/CRO or internally through physical and analytical testing. Make informed discussions based on scientific data
  • Contribute to drug product sections of regulatory filings such as INDs, IMPDs and NDAs
  • Stay updated on principles and theories relevant to drug development. Actively participate in cross-functional team meetings and contribute to development plan
  • Exhibit excellent writing and communication skills, both verbally and in writing. Interact effectively with colleagues

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE